| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6165505 | Urology | 2016 | 22 Pages |
Abstract
It appears that ROCK inhibitors can become an alternative worth considering in overactive bladder syndrome treatment, especially in the light of the findings pointing to the decreased efficiency of antimuscarinic drugs in the overactive bladder syndrome treatment of postmenopausal women.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Andrzej Wróbel, Tomasz Rechberger,